{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]

RxCUI
2630667
RxNorm name
{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]
Display name
{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]
Full name
{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8ed2003a-c801-411e-831e-d06079bb0d7c{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]BPCK24These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 200220241120
8ed2003a-c801-411e-831e-d06079bb0d7cOrenitram Month 1 Titration KitSY24These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 200220241120
8ed2003a-c801-411e-831e-d06079bb0d7cOrenitram Month 1 Titration KitPSN24These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 200220241120